Oncology
Global

Oncology Experts

David l. morse

Researcher
Deparment of Cancer Imaging and Metabolism
Moffitt Cancer Center
United States of America

David l. morse

Biography

Dr. David L. Morse is affiliated to Deparment of Cancer Imaging and Metabolism, Moffitt Cancer Center. Dr. David L. Morse is currently providing services as Researcher. Dr. David L. Morse has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. David L. Morse contributions have acclaimed recognition from honourable subject experts around the world. Dr. David L. Morse is actively associated with different societies and academies. Dr. David L. Morse academic career is decorated with several reputed awards and funding. Dr. David L. Morse research interests include Dr. Morse’s research projects are focused on the identification and validation of cell-surface markers for cancer, discovery of ligands or antibodies specific for binding validated markers, and the development of targeted molecular imaging probes and nanoagents for the detection and treatment of cancer. The ultimate goal of this work is to translate novel probes into the clinic for use in cancer diagnosis and staging, intraoperative margin detection and the targeted delivery of therapy..

Research Interest

Dr. Morse’s research projects are focused on the identification and validation of cell-surface markers for cancer, discovery of ligands or antibodies specific for binding validated markers, and the development of targeted molecular imaging probes and nanoagents for the detection and treatment of cancer. The ultimate goal of this work is to translate novel probes into the clinic for use in cancer diagnosis and staging, intraoperative margin detection and the targeted delivery of therapy.

Publications

  • Khabibullin AR, Karolak A, Budzevich MM, Woods LM, Martinez MV, McLaughlin ML, Morse DL. SU‐C‐204‐03: DFT Calculations of the Stability of DOTA‐Based‐Radiopharmaceuticals. Medical physics. 2016 Jun 1;43(6):3314-.

  • Roy J, Putt KS, Coppola D, Leon ME, Khalil FK, Centeno BA, Clark N, Stark VE, Morse DL, Low PS. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget. 2016 Mar 22;7(12):14605.

  • McFarland C, Yaglom JA, Wojtkowiak JW, Scott J, Morse DL, Sherman MY, Mirny L. The damaging effect of passenger mutations on cancer progression. Cancer Research. 2017 Jan 1:canres-3283.

Global Experts from United States of America

Global Experts in Subject